Currently Enrolling
Trial Physician / Study Coordinator
James McMullen
Email Phone (303) 232-3366Site Name
Western Nephrology and Metabolic Bone Disease
5265 Vance St., Suite 200, Arvada, CO 80002
Find other locations for this trial:
Currently Enrolling
Eligibility Criteria
About the Drug
What is involved for the patient
Target Enrollment
105 participants
Estimated End Date
The estimated end date of enrollment of the study is in the second quarter of 2022